<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04836364</url>
  </required_header>
  <id_info>
    <org_study_id>19-03-1700</org_study_id>
    <nct_id>NCT04836364</nct_id>
  </id_info>
  <brief_title>Skincare Products and Environmental Health</brief_title>
  <official_title>Prevalence of Endocrine Disorders Among Children Exposed to Lavender Essential Oil and Tea Tree Essential Oils</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Franklin School of Integrative Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Franklin School of Integrative Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the potential for an association between the&#xD;
      development of prepubertal gynecomastia and history exposure to lavender essential oil, tea&#xD;
      tree essential oil, and other essential oils.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being informed about the study and privacy, parents will give informed consent and&#xD;
      complete the APICHS (Aromatic Plant Ingredient &amp; Child Health Survey), a validated&#xD;
      measurement tool for determining exposure to plant-based ingredients in pediatric personal&#xD;
      care products.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lifetime prevalence of prepubertal gynecomastia</measure>
    <time_frame>Baseline</time_frame>
    <description>The number of participants who were exposed to lavender and tea tree essential oils and had ever experienced prepubertal gynecomastia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lifetime prevalence of precocious puberty</measure>
    <time_frame>Baseline</time_frame>
    <description>The number of participants who were exposed to lavender and tea tree essential oils and experienced prepubertal gynecomastia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endocrine Disruption - Comparison between exposed and unexposed</measure>
    <time_frame>Baseline</time_frame>
    <description>The difference in rates of endocrine disorders between children who were exposed to lavender or tea tree essential oil and those who were not. Exposure is measured using the Aromatic Plant Ingredient and Child Health Survey (APICHS), which measures total exposure, providing a continuous variable ranging from 0 to unlimited exposures, and a dichotomous yes/no exposure outcome variable.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Gynecomastia</condition>
  <condition>Endocrine System Diseases</condition>
  <arm_group>
    <arm_group_label>Pediatric Cohort</arm_group_label>
    <description>Parents of children ages 2 to 15 years old will provide data using the APICHS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>There is no intervention; observation only.</description>
    <arm_group_label>Pediatric Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Parents of children aged 2 to 15 years old who live in the United States will be recruited&#xD;
        for this study. Emphasis is placed on obtaining a diverse sample which all states and&#xD;
        territories, in addition to a racially and SES diverse sample.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Parent of child aged 2-15 living in the United States&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Franklin Health Research Center</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessie Hawkins, PhD</last_name>
      <phone>615-642-1919</phone>
      <email>j.hawkins@franklinhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 5, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prepubertal Gynecomastia</keyword>
  <keyword>Essential Oils</keyword>
  <keyword>Lavender</keyword>
  <keyword>Tea Tree</keyword>
  <keyword>Endocrine Disruption</keyword>
  <keyword>Pediatric Environmental Health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gynecomastia</mesh_term>
    <mesh_term>Endocrine System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

